Prognostic value of the presence and development of atrial fibrillation in patients with advanced chronic heart failure

European Heart Journal

Volumn 21, Issue 15, 2000, Pages 1238-1245

  Crijns, H J G M ^a   Tjeerdsma, G ^a   De Kam, P J ^a   Boomsma, F ^a   Van Gelder, I C ^a   Van Den Berg, M P ^a   Van Veldhuisen, D J ^a  

^a NONE

Author keywords

Atrial fibrillation; Chronic heart failure; Prognosis

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD PRESSURE; DISEASE SEVERITY; FEMALE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; SINUS RHYTHM;

AGED; ATRIAL FIBRILLATION; DISEASE PROGRESSION; ELECTROCARDIOGRAPHY; FEMALE; HEART FAILURE, CONGESTIVE; HEART RATE; HUMANS; MALE; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 0033916120     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.1999.2107     Document Type: Article

References (31)

1. Benjamin EJ, Levy D, Vazari SM, D'Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort study: the Framingham Heart Study. JAMA. 271:1994;840-844.
2. Önurdarson PT, Thorgeirsson G, Jonmundsson E, Sigfusson N, Hardarson Th. Chronic atrial fibrillation: epidemiologic features and 14 years follow-up: a case-control study. Eur Heart J. 3:1987;521-527.
3. Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death. The Framingham Heart Study. Circulation. 98:1998;946-952.
4. Pedersen OD, Bagger H, Køber L, Torp-Pedersen C. The occurrence and prognostic significance of atrial fibrillation/-flutter following acute myocardial infarction. Eur Heart J. 20:1999;748-754.
5. Middlekauff HR, Stevenson WG, Stevenson LW. Prognostic significance of atrial fibrillation in advanced heart failure. A study of 390 patients. Circulation. 84:1991;40-48.
6. Carson PE, Johnson GR, Dunkman WB, Fletcher RD, Farrel L, Cohn JN. The influence of atrial fibrillation on prognosis in mild to moderate heart failure. The V-HeFT Studies. Circulation. 87:1993;VI-102-10.
7. Crijns HJGM, Van den Berg MP, Van Gelder IC, Van Veldhuisen DJ. Management of atrial fibrillation in the setting of heart failure. Eur Heart J. 18:1997;C45-9.
8. Senni M, Tribouilly CM, Rodeheffer RJ. Congestive heart failure in the community. Trends in incidence and survival in a 10-year period. Arch Intern Med. 159:1999;29-34.
9. Van den Berg MP, Tuinenburg AE, Crijns HJGM, Van Gelder IC, Gosselink AT, Lie KI. Heart failure and atrial fibrillation: current concepts and controversies. Heart. 77:1997;309-313.
10. Lévy S, Maarek M, Coumel P. Characterization of different subsets of atrial fibrillation in general practice in France. The ALFA Study. Circulation. 99:1999;3028-3035.
11. Braunwald E. Shattuck Lecture - Cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. N Engl J Med. 337:1997;1360-1369.
12. Stevenson WG, Stevenson LW, Middlekauf HR. Improving survival for patients with atrial fibrillation and advanced heart failure. J Am Coll Cardiol. 28:1996;1458-1463.
13. Dries DL, Exner DV, Gersch BJ, Domanski MJ, Waclawiw MA, Stevenson LW. Atrial fibrillation is associated with and increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction. A retrospective analysis of the SOLVD Trials. J Am Coll Cardiol. 32:1998;695-703.
14. Pozzoli M, Cioffi G, Traversi E, Pinna GD, Cobelli F, Tavazzi L. Predictors of primary atrial fibrillation and concomitant clinical and hemodynamic changes in patients with chronic heart failure: a prospective study in 344 patients with baseline sinus rhythm. J Am Coll Cardiol. 32:1998;197-204.
15. Deedwania PC, Singh BN, Ellenbogen K, Fisher S, Fletcher R, Singh SN. Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation. Circulation. 98:1998;2574-2579.
16. Hampton JR, Van Veldhuisen DJ, Kleber FX. Randomised study of effect of ibopamine on survival in patients with advanced severe heart failure. Lancet. 349:1997;971-977.
17. Van Veldhuisen DJ, Boomsma F, De Kam PJ. Influence of age on neurohormonal activation and prognosis in patients with moderate to severe chronic heart failure. Eur Heart J. 19:1998;753-760.
18. Tuinenburg AE, Van Veldhuisen DJ, Boomsma F, Van den Berg MP, De Kam PJ, Crijns HJGM. Comparison of plasma neurohormones in congestive heart failure patients with atrial fibrillation versus patients with sinus rhythm. Am J Cardiol. 81:1998;1207-1210.
19. Yasue H, Yoshimura M, Sumida H. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation. 90:1994;195-203.
20. Cox DR. Regression models and life tables. J R Stat Soc. 34:1972;187-202.
21. Atwood JE, Myers J, Sullivan M. Maximal exercise testing and gas exchange in patients with chronic atrial fibrillation. J Am Coll Cardiol. 11:1988;508-513.
22. Gosselink ATM, Smit AJ, Crijns HJGM, Hillege HL, Lie KI. Alteration of peripheral vasodilatory reserve capacity after cardioversion of atrial fibrillation. Eur Heart J. 17:1996;926-934.
23. Cobbe SM. Using the right drug. A treatment algorithm for atrial fibrillation. Eur Heart J. 18:1997;C33-9.
24. Mahoney P, Kimmel S, DeNofrio D, Wahl P, Loh E. Prognostic significance of atrial fibrillation in patients at a tertiary medical center referred for heart transplantation because of severe heart failure. Am J Cardiol. 83:1999;1544-1547.
25. Cameron A, Schwartz MJ, Kronmal RA, Kosinski AS. Prevalence and significance of atrial fibrillation in coronary artery disease (CASS registry). Am J Cardiol. 61:1988;714-717.
26. Lake FR, McCall MG, Cullen KJ, Rosman DL, De Klerk NH. Atrial fibrillation and mortality in an elderly population. Aust NZ J Med. 19:1989;321-326.
27. Psaty BM, Manolio TA, Kuller LH. Incidence of and risk factors for atrial fibrillation in older adults. Circulation. 96:1997;2455-2461.
28. Crenshaw BS, Ward SR, Cranger CB, Stebbins AL, Topol EJ, Califf RM. Atrial fibrillation in the setting of acute myocardial infarction: The GUSTO-1 experience. J Am Coll Cardiol. 30:1997;406-413.
29. Van den Berg MP, Tuinenburg AE, Van Veldhuisen DJ, De Kam PJ, Crijns HJGM. Cardioversion of atrial fibrillation in the setting of mild to moderate heart failure. Int J Cardiol. 63:1998;63-70.
30. Van Gelder IC, Crijns HJGM, Tieleman RG. Chronic atrial fibrillation. Success of serial cardioversion therapy and safety of oral anticoagulation. Arch Intern Med. 156:1996;2585-2592.
31. Farshi R, Kistner D, Sarma JS, Longmate JA, Singh BN. Ventricular rate control in chronic atrial fibrillation during daily activity and programmed exercise: a crossover open-label study of five drug regimens. J Am Coll Cardiol. 33:1999;304-310.